Editor's Note A February 26 letter in JAMA Network reported a revised legal standard for medical negligence in the US, shifting from traditional reliance on customary practice toward a more patient-centered, evidence-based definition of “reasonable care.” The American Law Institute (ALI) updated its framework in 2024, retaining elements of prevailing…

Read More

The poster presentations at the 2024 OR Manager Conference showcased exceptional perioperative initiatives, highlighting advancements and innovative practices. From streamlining documentation and optimizing billing processes to ensuring patient and staff safety in postanesthesia settings, the posters selected last year showed the ingenuity and dedication of healthcare professionals committed to excellence…

Read More

Editor's Note Universitätsmedizin Berlin reduced anesthesia-related carbon emissions by more than 80% since 2018 by eliminating high-impact anesthetic gases, implementing education initiatives, and revising clinical guidelines, according to a February 27 report in Medical Xpress. The hospital’s efforts targeted desflurane, an anesthetic gas with an extreme climate impact—nearly 8,000 times…

Read More

Editor's Note The US Food and Drug Administration (FDA) designated Getinge’s recall of Vaporizer Sevoflurane Maquet Filling and Sevoflurane Quick-Fil and Philips’ recall of Tack Endovascular Systems as Class 1s, the most severe category indicating serious risk of injury or death. The Getinge recall is an expansion of a 2024…

Read More

Editor's Note Prolonged exposure to general anesthesia during surgery contributes to long-term cognitive decline, affecting executive functioning, selective attention, mental speed, and information processing, according to a February 18 study published in the European Journal of Anaesthesiology. This prospective longitudinal cohort study followed 1,823 adults aged 25–84 in the Netherlands…

Read More

Editor's Note Insufficient awareness of drug interactions with hormonal contraceptives (HCs) among anesthesia providers could lead to unintended pregnancies and preventable health consequences, according to survey published in Anesthesia & Analgesia. Physician’s Weekly covered the news February 27. The article specifically cites sugammedex and aprepitant, both of which are widely…

Read More

Editor's Note Using powerful synthetic opioids remifentanil and sufentanil during surgery increases risk of patients suffering during recovery, according to a study in the journal Regional Anesthesia & Pain Medicine. HealthDay reported the news February 27. According to the article, researchers analyzed data from 971 patients who underwent surgery—37% orthopedic…

Read More

Editor's Note The OR Business Management Conference this year for the first time offered a lineup of sessions that was fully dedicated to content relevant to ambulatory surgery centers (ASCs). In this session, Collin Pick, MSN, CRNA, ARNP, CMPE, chief of anesthesia, Physician Partners of America, explored the ongoing anesthesia…

Read More

Editor's Note Recent legislative efforts in Florida and Mississippi aim to expand the authority of advanced practice registered nurses (APRNs) with measures that would remove supervisory requirements and allow independent practice for certain nurse practitioners. The efforts underscore an ongoing, nationwide debate over the role of APRNs in addressing provider…

Read More

Editor's Note Implementing a multimodal analgesia-based enhanced recovery after surgery (ERAS) protocol significantly reduced both intraoperative opioid administration and postoperative opioid prescriptions in cardiac surgery patients, according to a January 5 report in Anesthesiology News. The findings were presented at the 2024 International Anesthesia Research Society meeting by Montefiore-Einstein Center…

Read More